|

Arthritis Clinical Trials in Alabama

23 recruiting studies across 7 cities

All Trials in Alabama

Phase
Trial Phase Location
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid ArthritisPhase 1Anniston
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)Phase 1Anniston
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.Phase 1Anniston
ConsideRAte Study - Splenic Stimulation for RAN/AAnniston
RA-PRO PRAGMATIC TRIALPhase 3Auburn
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis PainPhase 2Birmingham
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainPhase 2Birmingham
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsPhase 2Birmingham
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 3Birmingham
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the KneePhase 2Birmingham
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)Phase 3Birmingham
Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease TreatmentPhase 2Birmingham
Diet Interventions: Remitted and Evaluated as Complementary Treatments for PainN/ABirmingham
Improving Gout Care After an ED VisitN/ABirmingham
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—Birmingham
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and OsteoarthritisPhase 3Birmingham
Rehabilitation for Arthritis of The Knee: mainTaining Improvement for VeteransPhase 3Birmingham
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE ParticipantsPhase 1Birmingham
Study of Dapansutrile Tablets in Subjects With an Acute Gout FlarePhase 2/3Birmingham
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1Birmingham
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPhase 3Mobile
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in GoutPhase 4South Birmingham
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.Phase 2Tuscaloosa

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.